Medicover

Interim Report January-March 2018 - Seite 2

0.067

0.040

68%

0.157

Diluted earnings per share, €

0.067

0.040

68%

0.157

EBITDA1

15.0

13.2

14%

55.0

EBITDA margin, %[1]

9.3%

9.3%

9.5%

[1] For Alternative Performance Meassure definitions and reconciliations, refer to note 6 

This information is information that Medicover AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 8.00 (CET) on 26 April 2018. This interim report and other information about Medicover, is available at medicover.com.

---

---

For further information, please contact:
Paula Treutiger
Corporate Communications & Investor Relations
Director  
Phone: [phone]
Mail: [e-mail]

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/medicover/r/interim-report-january-march-2018,c2505870

The following files are available for download:

http://mb.cision.com/Main/15662/2505870/829741.pdf

Interim report January-March 2018